Gollob Jared - Insider Transactions
Insider Type
individual
Companies
1
Average
343,088
Total Txns
11
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 9 | -9 | 0.00 | 3,599,181.95 | -3,599,181.95 |
| 2025 | 0 | 2 | -2 | 0.00 | 174,785.54 | -174,785.54 |
| Total: | 0 | 11 | 10 | 0.00 | 3,773,967.49 | -3,773,967.49 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
31.00 USD |
1,045 Sold |
32,400 USD |
03/03/2025 | 03/03/2025 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
30.33 USD |
4,695 Sold |
142,386 USD |
03/03/2025 | 03/03/2025 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
45.59 USD |
13,281 Sold |
605,522 USD |
15/07/2024 | 16/07/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
46.10 USD |
9,864 Sold |
454,696 USD |
15/07/2024 | 16/07/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
45.15 USD |
16,455 Sold |
742,925 USD |
15/07/2024 | 15/07/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
43.26 USD |
216 Sold |
9,343 USD |
01/03/2024 | 04/03/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
41.41 USD |
2,022 Sold |
83,738 USD |
01/03/2024 | 04/03/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
42.39 USD |
1,106 Sold |
46,886 USD |
01/03/2024 | 04/03/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
45.00 USD |
400 Sold |
18,000 USD |
27/02/2024 | 27/02/2024 |
| Kymera Therapeutics, Inc. Common Stock US5015751044 |
35.39 USD |
38,739 Sold |
1,371,058 USD |
09/02/2024 | 09/02/2024 |